title: The impact of European embryonic stem cell patent decisions on research strategies.
authors.affiliation: 1] UMR1027, INSERM and Université Toulouse III-Paul Sabatier, Toulouse, France [2] Center for Global Health Policy, School of Global Studies, University of Sussex, Brighton, UK, and IRDEIC, Université Toulouse 1 Capitole, Toulouse, France.
authors.forename: Aurélie
authors.initials: A
authors.lastname: Mahalatchimy
authors.affiliation: UMR1027, INSERM and Université Toulouse III-Paul Sabatier, Toulouse, France.
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: Rial-Sebbag
authors.affiliation: UMR1027, INSERM and Université Toulouse III-Paul Sabatier, Toulouse, France.
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Duguet
authors.affiliation: UMR1027, INSERM and Université Toulouse III-Paul Sabatier, Toulouse, France.
authors.forename: Florence
authors.initials: F
authors.lastname: Taboulet
authors.affiliation: UMR1027, INSERM and Université Toulouse III-Paul Sabatier, Toulouse, France.
authors.forename: Anne
authors.identifier: 0000000187933644
authors.initials: A
authors.lastname: Cambon-Thomsen
mesh_terms: D035843:Biomedical Research; D053595:Embryonic Stem Cells / Q000166:cytology*; D005062:European Union; D006801:Humans; D010330:Patents as Topic